Effects of a Lifestyle Intervention in Young Women with GDM and Subsequent Diabetes
by
, and
Gang Hu
1,*,†
,
Huikun Liu
2,†,
Junhong Leng
2,†,
Leishen Wang
2,
Weiqin Li
2,
Shuang Zhang
2,
Wei Li
2,
Gongshu Liu
2,
Huiguang Tian
2,
Shengping Yang
1,
Zhijie Yu
3,
Xilin Yang
4 and
Jaakko Tuomilehto
5,6,7 
1
Pennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, LA 70808, USA
2
Tianjin Women’s and Children’s Health Center, Tianjin 300071, China
3
Population Cancer Research Program, Dalhousie University, Halifax, NS B3H 4R2, Canada
4
Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin 300070, China
5
Department of Public Health, University of Helsinki, 00014 Helsinki, Finland
6
Population Health Unit, Finnish Institute for Health and Welfare, 00271 Helsinki, Finland
7
Saudi Diabetes Research Group, King Abdulaziz University, Jeddah 21589, Saudi Arabia
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Nutrients 2022, 14(24), 5232; https://doi.org/10.3390/nu14245232
Submission received: 17 November 2022
/
Revised: 1 December 2022
/
Accepted: 2 December 2022
/
Published: 8 December 2022
(This article belongs to the Special Issue Healthy Lifestyle Interventions to Combat Noncommunicable Disease)
Abstract
:The purpose of this study was to examine whether a 9-month intensive lifestyle intervention could lead to weight loss and improve cardiovascular risk factors among young women with both gestational diabetes mellitus (GDM) and newly diagnosed diabetes. A total of 83 young women, who had GDM and were subsequently diagnosed as type 2 diabetes at an average of 2.6 years after delivery, participated in a 9-month intensive lifestyle intervention and a follow-up survey at 6–9 years postintervention. After the 9-month intervention, these women had a weight loss of 2.90 kg (−4.02% of initial weight), decreased waist circumference (−3.12 cm), body fat (−1.75%), diastolic blood pressure (−3.49 mmHg), fasting glucose (−0.98 mmol/L) and HbA1c (−0.72%). During the 6–9 years postintervention period, they still had lower weight (−3.71 kg; −4.62% of initial weight), decreased waist circumference (−4.56 cm) and body fat (−2.10%), but showed a slight increase in HbA1c (0.22%). The prevalence of using glucose-lowering agents increased from 2.4% at baseline to 34.6% after the 9-month lifestyle intervention, and to 48.4% at 6–9 years postintervention. A 9-month intensive lifestyle intervention can produce beneficial effects on body weight, HbA1c and other cardiovascular risk factors among young women with previous GDM who subsequently developed new diabetes.
1. Introduction
Gestational diabetes mellitus (GDM), defined as any degree of glucose intolerance with onset or first recognition during pregnancy, is a common pregnancy outcome [1]. GDM affects about 8% of pregnant women in the US and in China [2,3,4]. Women with prior GDM have almost a ten times higher risk of developing type 2 diabetes as compared with women with normoglycemic pregnancy, with the highest risk during 1–5 years after GDM [5]. About 20% of women with prior GDM will develop type 2 diabetes within 10 years after pregnancy, and more than 40% within 30 years [6]. Women with prior GDM also have increased risks of obesity, hypertension, dyslipidemia, metabolic syndrome, and cardiovascular disease (CVD) [7,8,9,10,11,12].
As a part of the postpartum care of GDM, American Diabetes Association (ADA) recommends a 2 h 75 g oral glucose tolerance test (OGTT) for women with recent GDM to detect persistent diabetes at 4–12 weeks postpartum and then repeatedly every 1 to 3 years thereafter [1]. Women with GDM and subsequent undiagnosed diabetes at 1–5 years postpartum are generally young and have a very low awareness of diabetes. Some studies have found that participants with newly diagnosed diabetes have a higher risk of CVD compared with those with normal glucose [13,14]. Although recent randomized controlled trials, such as the Look AHEAD (Action for Health in Diabetes) trial, have indicated that an intensive lifestyle intervention could help in losing weight and improve HbA1c among overweight or obese adults with type 2 diabetes [15], no studies have assessed short- and long-term effects of a lifestyle intervention on cardiovascular risk factors among young women with GDM and subsequent undiagnosed diabetes. The aim of this single-arm trial was to examine whether a 9-month intensive lifestyle intervention could lead to weight loss and improve cardiovascular risk factors among young women with both GDM and newly diagnosed diabetes and to investigate to what extent such effects might sustain in the long term.
2. Materials and Methods
2.1. Study Design and Participants
The present study was a single-arm 9-month trial carried out at the Tianjin Women’s and Children’s Health Center, Tianjin, China, which was part of The Tianjin Gestational Diabetes Mellitus Prevention Program (TGDMPP) [16,17,18,19]. The study design of TGDMPP, including recruitment, screening visits, and inclusion and exclusion criteria, has been described in detail elsewhere [16,17,18,19]. Briefly, 4644 women with GDM diagnosed on the basis of the 1999 World Health Organization (WHO) criteria [20] from six urban districts in Tianjin between 2005 and 2009 were recruited 1–5 years after delivery, and 1263 women (27% participation rate) aged more than 24 years old returned and completed the baseline survey administered by health workers from the study center between 2009 and 2011 [16,17,18,19]. There were no differences in the OGTT at 26–30 weeks’ gestation with regard to age (28.9 vs. 28.7 years), fasting plasma glucose (5.34 vs. 5.34 mmol/L), 2 h glucose (9.23 vs. 9.16 mmol/L), and the prevalence of impaired glucose tolerance (90.9 vs. 91.8%) and diabetes (9.1 vs. 8.2%) between the returned and unreturned women with GDM. Among the 1263 women with prior GDM who finished the baseline survey, 83 were diagnosed as having type 2 diabetes by a 2 h 75 g OGTT and confirmed by another 2 h 75 g OGTT according to the 2005 ADA criteria [21]. These 83 women with prior GDM and newly diagnosed type 2 diabetes finally participated in a 9-month intensive lifestyle intervention program and clinical visits and also completed a follow-up survey at 6–9 years postintervention (Figure 1). Ethics approval was granted by the Human Subjects Committee of the Tianjin Women’s and Children’s Health Center, and all participants provided written informed consent. This trial has been registered with ClinicalTrials.gov, number NCT01554358.
The inclusion criteria for women were: (1) age 20–49 years at the baseline survey; and (2) GDM detected between 2005 and 2009. The exclusion criteria were: (1) age < 20 or ≥50 years; (2) presence of diabetes before pregnancy; (3) taking medicines known to alter OGTT at the baseline survey; (4) presence of any chronic diseases that could seriously reduce their life expectancy or their ability to participate in the trial; (5) unable or unwilling to give informed consent or communicate with study staff; and (6) currently pregnant, or planning to become pregnant in the next two years [16].
2.2. Screening Visit
The screening visit included informed consent and the completion of a detailed medical eligibility questionnaire. The eligibility screening questionnaire was based on the inclusion/exclusion criteria described above. If eligible, women finished the baseline survey at the same visit. At the baseline survey, all women completed a self-administered questionnaire and underwent a physical examination. They also completed a 3-day 24 h food record using methods for dietary record collections taught by a dietitian.
2.3. Run-In
Before the intervention, eligible participants were given two classes in a 2-week “run-in” period on general principles of lifestyle intervention for the management of type 2 diabetes and obesity. Participants discussed their previous experiences with lifestyle changes and obstacles encountered. The accumulating evidence that showed lifestyle intervention is effective for the management of type 2 diabetes and obesity was presented. The specific lifestyle intervention program began after the run-in.
2.4. Lifestyle Intervention
Major elements of the intervention included five face-to-face sessions with study dietitians and two telephone calls during the 9-month lifestyle intervention program.
Dietary intervention (1–4): In the first week, each participant individually met with a dietitian who instructed the participant on how to achieve the five goals of the intervention, including (1) a reduction of 5 to 10% of initial body weight in women with body mass index (BMI) ≥ 24 kg/m2 by reducing at least 10% of total calories in their normal meals, and no weight loss for GDM women with BMI < 24 kg/m2, using the Chinese BMI classification standard [22]; (2) total fat intake < 30% of consumed energy; (3) carbohydrate intake 55–65% of consumed energy; (4) fiber intake 20–30 g per day; and (5) moderate or vigorous exercise for at least 30 min daily, seven days each week [16,17,18,19]. Based on each participant’s current status of body weight, breastfeeding, and physical activity, along with food and nutrient intakes that had been assessed at the baseline survey examination, the dietitian provided advice on how to modify their diet, which included (a) intake of appropriate energy, (b) inclusion of appropriate amounts of fish, eggs, low-fat milk, lean meat, and reduction in fatty meat and animal fat in the diet, (c) avoidance/reduction of simple sugars and refined carbohydrates, and (d) inclusion of more fiber-rich food, such as whole grains, standard grade wheat flour, corn/corn starch, brown rice, vegetables and fruits. To help participants meet these healthy diet goals, the dietitian provided the participants with a suggestive daily menu for five days. A dietitian established a minimum of five breakfasts, five lunches, and five dinners that the women were recommended to consume within the 5-day cycle menu, taking into consideration individual food preferences. Moreover, the dietitian taught each participant to select a diet that matched their specific diet prescription for macronutrients and energy and also introduced a method to exchange foods, as depicted in a handbook.
Physical activity intervention (Weeks 1–4): The physical activity goal was to gradually increase the physical activity from 15 to 30 min per day during the first four weeks. Participants had been instructed to engage in moderate or vigorous physical activity during commuting (walking or cycling to/from work) or leisure time (e.g., walking, bicycling, etc.) for at least 15 min per day, seven days per week during Week 1. The level of physical activity was planned to be increased to at least 30 min per day, seven days per week in Week 4, and maintained there during the entire trial period.
Diet and physical activity monitoring (Week 4–Month 9): Each participant completed a questionnaire on changes in major dietary and physical activity habits at the last visit, and provided their 3-day 24 h food records four times during the 9-month period for assessment by the dietitian. The dietitian reviewed questionnaires and food records, calculated the nutrient intakes using the dietary analysis software (version 2.3) developed by China CDC, provided an assessment of deviations from the suggested diets and exercises, and then offered specific suggestions at each visit. Body weight was measured at each visit.
Telephone intervention: The participants received two phone calls to encourage continued compliance with the intervention during the 9-month trial. The dietitian adjusted treatment advice to improve dietary adherence to weight loss goals. Almost 100% of mothers have mobile phone service.
2.5. Measurement
All study participants filled in a questionnaire at the baseline survey about their sociodemographic characteristics (age, marital status, education, income and occupation), history of GDM (values of fasting and 2 h glucose in the OGTT and treatment of GDM during the pregnancy), family history (diabetes, coronary heart disease, stroke, cancer and hypertension), medical history (hypertension, diabetes, and hypercholesterolemia), pregnancy outcomes (pre-pregnancy weight, weight gain in pregnancy, and number of children), postpartum weight and fasting glucose status, dietary habits (a self-administered food frequency questionnaire [FFQ] to measure the frequency and quantity of intake of 33 major food groups and beverages during the past year) [23], alcohol intake, smoking habits, physical activity (the frequency and duration of five domains of physical activity, including occupational, commuting [walking or cycling to/from work], leisure time [11 recreational activities], household [cooking, washing clothes, cleaning, and looking after children] and sedentary activities) [24,25], and sleep status (duration of usual sleep and night shift work).
Changes in lifestyle were measured using a questionnaire on changes in major dietary and physical activity habits at the last visit, a 3-day 24 h food record was completed at each clinical visit, and a self-administered questionnaire was completed at follow-up visits at Month 9 and Years 6–9. The performance of 3-day 24 h food records [23], the FFQ [23], and the above questionnaire on assessing physical activity [24,25] were validated in the China National Nutrition and Health Survey in 2002.
Body weight, height, waist and hip circumferences, body fat (measured using Tanita Body Composition Analyzers SC-240, Arlington Heights, IL), blood pressure, and heart rate were measured in all women using a standardized protocol at the visits of baseline, Month 9 and Years 6–9. Body weight was also measured at each clinical visit within the first 9 months. BMI was calculated as weight divided by the square of height. Peripheral venous EDTA-blood samples were collected from all participants after fasting for at least 10 h. Plasma glucose and lipid profile (total cholesterol, high-density lipoprotein [HDL] cholesterol, and triglycerides) were measured with an automatic analyzer (Toshiba TBA-120FR, Tokyo, Japan). Serum insulin was determined by an electro-chemiluminescent immunoassay (Bayer ADVIA Centaur CP, Barmen, Germany). Glycated hemoglobin (HbA1c) was measured using an Automatic Glycohaemoglobin Analyzer (ADAMS A1c HA-8160; Arkray, Kyoto, Japan).
2.6. Follow-Up and Outcome Indices
The primary outcomes of the trial were changes in body weight and HbA1c from baseline to Month 9 as well as from baseline to Years 6–9. The secondary outcomes were changes in waist circumference, body fat, blood pressure, fasting plasma glucose, fasting serum insulin, plasma total, HDL, and low-density lipoprotein (LDL) cholesterol, plasma triglycerides, and the use of glucose-lowering agents from baseline to Month 9 and from baseline to Years 6–9.
2.7. Statistical Analysis
A one-way ANOVA and chi-square test were used to analyze the differences in continuous baseline measures and in categorical measures among women with GDM and newly diagnosed diabetes who attended and absented Month 9 and Years 6–9 follow-up visits, respectively. We assessed changes in body weight, energy intake, and leisure time physical activity from baseline to Months 1, 3, 6 and 9. A two-tailed paired t test was used to analyze the differences in continuous measures between the two groups from baseline to Month 9 and from baseline to Years 6–9. Mean changes and their SD were calculated. An intention-to-treat analysis that included all participants was conducted in this study. A monotone missing pattern was observed among the missing values, and a multiple imputations using a regression model were performed. A p-value < 0.05 was considered statistically significant. Statistical analyses were performed with IBM SPSS Statistics 25.0 (IBM SPSS, Chicago, IL, USA) and SAS for Windows, version 9.4 (SAS Institute, Inc, Cary, NC, USA).
3. Results
A total of 68 women finished the 9-month lifestyle intervention, and 39 women attended the 6–9 years postintervention survey. Mean values of age among these participants were 32.7 at baseline, 33.8 after the 9-month lifestyle intervention, and 39.5 at the 6–9 years postintervention (Table 1). Baseline characteristics were almost similar among all participants with GDM and newly diagnosed diabetes who attended and who did not attend Month 9 and Years 6–9 follow-up visits except for a younger age group of women absenting the follow-up visits (Table 1).
Table 2 and Table S1 presented changes in body weight, energy intake and leisure time physical activity from baseline to Months 1, 3, 6 and 9. Participants who completed interventions at one of the visits at Months 1, 3, 6 and 9 lost an average of 1.82 kg weight at Month 1, 2.81 kg at Month 3, 3.21 kg at Month 6, and 2.90 kg at Month 9. Participants reduced their daily energy intake ranging from 62 up to 242 kcal and increased daily leisure time physical activity from 4.3 up to 8.5 min from baseline to Months 1–9.
During the 9-month intervention, women lost their weight of average 2.90 kg (−4.02% of initial weight), decreased their BMI (−1.12 kg/m2), waist circumference (−3.12 cm), body fat (−1.75%), diastolic blood pressure (−3.5 mmHg), fasting plasma glucose (−0.98 mmol/L), fasting serum insulin (−15.5 pmol/L) and HbA1c (−0.72%) (Table 3, Table S2 and S3). During the 6–9 years postintervention, women still had lower weight (−3.71 kg; −4.62% of initial weight), decreased BMI (−1.57 kg/m2), waist circumference (−4.56 cm), and body fat (−2.10%), but had a slight increase in their HbA1c (0.22%). The prevalence of the use of glucose-lowering drugs increased from 2.4% at baseline to 34.6% after the 9-month lifestyle intervention, and to 48.4% at 6–9 years postintervention.
No serious adverse events occurred during the 9-month lifestyle intervention and the 6–9 years postintervention.
4. Discussion
Among young women with GDM and subsequent newly diagnosed diabetes at an average of 2.6 years after delivery, who took part in a 9-month intensive lifestyle intervention from baseline to follow-up, significant weight loss, decreased HbA1c, and improved cardiovascular risk factors were observed. The weight loss effect of this lifestyle intervention was sustained for at least 6 years.
Overweight and obesity are more common among patients with type 2 diabetes [26,27] as well as among women with prior GDM [16,28]. Thus, weight loss is recommended by the ADA for overweight or obese patients with type 2 diabetes [29]. The Look AHEAD trial has found that the intensive lifestyle intervention can result in weight loss and improvements of HbA1c, blood pressure, and HDL cholesterol during the intervention and a modest weight loss was maintained during the postintervention follow-up period in 5145 overweight or obese adults with type 2 diabetes, but it did not reduce cardiovascular events [15,30,31]. A recent review including 11 trials indicated that weight-loss dietary or lifestyle intervention trials led to a weight loss of < 5% of initial weight at 12 months among overweight or obese people with type 2 diabetes [32]. Only two studies had weight losses of > 5% in 12-month trials (the Mediterranean-style diet in the Esposito trial and the intensive lifestyle intervention in the Look AHEAD trial). They also had a significant decrease in HbA1c and significant improvements in lipids and blood pressure [32]. All these trials, however, focused on middle-aged or older adults with a history of type 2 diabetes [32]. No trials have assessed the short- and long-term cardiovascular effects of a lifestyle intervention among younger women with prior GDM and subsequent newly diagnosed diabetes. Nevertheless, several studies have found that people with type 2 diabetes diagnosed at < 40 years of age demonstrably increased their risk of CVD and had a reduced life expectancy [33,34]. Moreover, women with recent GDM and undiagnosed diabetes at 1–5 years postpartum are relatively young, have a very low awareness of diabetes, and have an increased risk of obesity, hypertension, dyslipidemia, metabolic syndrome, and CVD [7,8,9,10,11].
All participants in our study were relatively young, aged 32.7 years at baseline, 33.8 years after the 9-month lifestyle intervention, and 39.5 years at 6–9 years postintervention. All 83 participants had a history of GDM, and almost all of them were newly diagnosed with type 2 diabetes 2.6 years after delivery, while only 2.4% of them used glucose-lowering drugs. The present study showed that women who participated in this 9-month intensive postpartum lifestyle intervention, from baseline to follow-up, significantly lost weight, decreased HbA1c, and improved blood pressure, fasting glucose and insulin. We also found that a significant reduction in daily energy intake (227–242 kcal/d) within the first six months of intervention and an increase in leisure time physical activity (4.3–8.5 min/day) during the first nine months of intervention were associated with the significant weight loss during the 9-month intervention. The weight loss effect with a lifestyle intervention persisted for at least 6 years during the postintervention follow-up period; however, HbA1c levels slightly increased in this long-term period. Several studies have found that decreased HbA1c levels were associated with a decrease in major CVD among patients with type 2 diabetes [35,36].
An important strength of the present study is that it is the first to evaluate the short- and long-term cardiovascular effects of a lifestyle intervention among women with GDM and subsequent diabetes. This study’s participants were younger at baseline and during follow-up of the intervention, and they both had GDM and undiagnosed type 2 diabetes at an average of 2.6 years after delivery. The major limitation of the study is the single-arm trial design. Thus, we cannot distinguish the effects of a lifestyle intervention from the effects due to other reasons. Another limitation is the 82% retention rate during the 9-month intensive lifestyle intervention and the 47% retention rate at the postintervention follow-up survey at 6–9 years. However, the retention rate of the present study during the 9-month intensive lifestyle intervention was similar to that of the POUNDS Lost study (80%), another large weight loss RCT [37], and higher than those of other large GDM intervention RCTs, such as the Gestational Diabetes’ Effects on Moms study (67.3%) [38]. In addition, an intention-to-treat analysis that included all participants was conducted in the present study.
5. Conclusions
We found that young women with GDM and newly diagnosed diabetes who participated in a 9-month intensive lifestyle intervention had 4.0% weight loss, 0.72% decrease in HbA1c, and decreased waist circumference and blood pressure from baseline to follow-up. The weight loss effect with such an intensive lifestyle intervention persisted for at least 6 years with a weight loss of 4.6% from the initial body weight, while HbA1c slightly increased in the long term.
Supplementary Materials
The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/nu14245232/s1. Table S1. Changes in body weight, energy intake and leisure time physical activity from baseline to the end of Months 1, 3, 6 and 9 visits among participants who finished follow-up visits. Table S2. Changes in selected clinical and metabolic variables from baseline to the end of Month 9 among participants who finished follow-up visit. Table S3. Changes in selected clinical and metabolic variables from baseline to Month 9 and Years 6–9.
Author Contributions
G.H., H.L. and J.L. designed the study, acquired data, performed statistical analyses and drafted the manuscript. J.T. designed the study and critically revised the manuscript for important intellectual content. L.W., W.L. (Weiqin Li), S.Z., W.L. (Wei Li), G.L. and H.T. acquired data and critically revised the manuscript for important intellectual content. S.Y., Z.Y. and X.Y. critically revised the manuscript for important intellectual content. G.H. is the guarantor of this work and, as such, has full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. All authors have read and agreed to the published version of the manuscript.
Funding
This study was supported by a grant from the European Foundation for the Study of Diabetes (EFSD)/Chinese Diabetes Society (CDS)/Lilly programme for Collaborative Research between China and Europe. G.H. was partly supported by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK100790 and R01DK132011) and the National Institute of General Medical Sciences (U54GM104940) of the National Institutes of Health.
Institutional Review Board Statement
Ethics approval was granted by the Human Subjects Committee of the Tianjin Women’s and Children’s Health Center. Approval Code: 2009-01; 2013-03-01; 2017-03-01. Approval Dates: 2 August 2009, 1 March 2013, and 1 March 2017.
Informed Consent Statement
Informed consent was obtained from all subjects involved in the study.
Data Availability Statement
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Acknowledgments
We would like to appreciate all families for participating in the Tianjin Gestational Diabetes Mellitus Prevention Program.
Conflicts of Interest
The authors declare that there are no conflicts of interest associated with this manuscript.
References
- American Diabetes Association: 14. Management of Diabetes in Pregnancy. Standards of Medical Care in Diabetes-2022. Diabetes Care 2022, 45, S232–S243. [Google Scholar] [CrossRef] [PubMed]
- Zhou, T.; Du, S.; Sun, D.; Li, X.; Heianza, Y.; Hu, G.; Sun, L.; Pei, X.; Shang, X.; Qi, L. Prevalence and Trends in Gestational Diabetes Mellitus Among Women in the United States, 2006-2017: A Population-Based Study. Front. Endocrinol. 2022, 13, 868094. [Google Scholar]
- Zhang, F.; Dong, L.; Zhang, C.; Li, B.; Wen, J.; Gao, W.; Sun, S.; Lv, F.; Tian, H.; Tuomilehto, J.; et al. Increasing prevalence of gestational diabetes mellitus in Chinese women from 1999 to 2008. Diabet. Med. 2011, 28, 652–657. [Google Scholar] [CrossRef]
- Leng, J.; Shao, P.; Zhang, C.; Tian, H.; Zhang, F.; Zhang, S.; Dong, L.; Li, L.; Yu, Z.; Chan, J.C.; et al. Prevalence of Gestational Diabetes Mellitus and Its Risk Factors in Chinese Pregnant Women: A Prospective Population-Based Study in Tianjin, China. PLoS ONE 2015, 10, e0121029. [Google Scholar] [CrossRef] [PubMed]
- Vounzoulaki, E.; Khunti, K.; Abner, S.C.; Tan, B.K.; Davies, M.J.; Gillies, C.L. Progression to type 2 diabetes in women with a known history of gestational diabetes: Systematic review and meta-analysis. BMJ 2020, 369, m1361. [Google Scholar]
- Li, Z.; Cheng, Y.; Wang, D.; Chen, H.; Chen, H.; Ming, W.K.; Wang, Z. Incidence Rate of Type 2 Diabetes Mellitus after Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of 170,139 Women. J. Diabetes Res. 2020, 2020, 3076463. [Google Scholar] [CrossRef] [PubMed]
- Lauenborg, J.; Mathiesen, E.; Hansen, T.; Glumer, C.; Jorgensen, T.; Borch-Johnsen, K.; Hornnes, P.; Pedersen, O.; Damm, P. The prevalence of the metabolic syndrome in a danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. J. Clin. Endocrinol. Metab. 2005, 90, 4004–4010. [Google Scholar] [CrossRef] [Green Version]
- Carr, D.B.; Utzschneider, K.M.; Hull, R.L.; Tong, J.; Wallace, T.M.; Kodama, K.; Shofer, J.B.; Heckbert, S.R.; Boyko, E.J.; Fujimoto, W.Y.; et al. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care 2006, 29, 2078–2083. [Google Scholar] [CrossRef] [Green Version]
- Retnakaran, R.; Shah, B.R. Mild glucose intolerance in pregnancy and risk of cardiovascular disease: A population-based cohort study. CMAJ 2009, 181, 371–376. [Google Scholar] [CrossRef] [Green Version]
- Shen, Y.; Li, W.; Leng, J.; Zhang, S.; Liu, H.; Li, W.; Wang, L.; Tian, H.; Chen, J.; Qi, L.; et al. High risk of metabolic syndrome after delivery in pregnancies complicated by gestational diabetes. Diabetes Res. Clin. Pract. 2019, 150, 219–226. [Google Scholar] [CrossRef]
- Tobias, D.K.; Stuart, J.J.; Li, S.; Chavarro, J.; Rimm, E.B.; Rich-Edwards, J.; Hu, F.B.; Manson, J.E.; Zhang, C. Association of History of Gestational Diabetes with Long-term Cardiovascular Disease Risk in a Large Prospective Cohort of US Women. JAMA Intern. Med. 2017, 177, 1735–1742. [Google Scholar] [CrossRef] [PubMed]
- Shen, Y.; Wang, P.; Wang, L.; Zhang, S.; Liu, H.; Li, W.; Li, N.; Li, W.; Leng, J.; Wang, J.; et al. Gestational diabetes with diabetes and prediabetes risks: A large observational study. Eur. J. Endocrinol. 2018, 179, 51–58. [Google Scholar] [CrossRef]
- de Jong, M.; Woodward, M.; Peters, S.A. Diabetes, glycated hemoglobin, and the risk of myocardial infarction in women and men: A prospective cohort study of the UK Biobank. Diabetes Care 2020, 43, 2050–2059. [Google Scholar] [CrossRef]
- Hu, G.; Jousilahti, P.; Qiao, Q.; Peltonen, M.; Katoh, S.; Tuomilehto, J. The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease. J. Am. Coll. Cardiol. 2005, 45, 1413–1418. [Google Scholar] [CrossRef] [Green Version]
- Wing, R.R.; Bolin, P.; Brancati, F.L.; Bray, G.A.; Clark, J.M.; Coday, M.; Crow, R.S.; Curtis, J.M.; Egan, C.M.; Espeland, M.A.; et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N. Engl. J. Med. 2013, 369, 145–154. [Google Scholar]
- Hu, G.; Tian, H.; Zhang, F.; Liu, H.; Zhang, C.; Zhang, S.; Wang, L.; Liu, G.; Yu, Z.; Yang, X.; et al. Tianjin Gestational Diabetes Mellitus Prevention Program: Study design, methods, and 1-year interim report on the feasibility of lifestyle intervention program. Diabetes Res. Clin. Pract. 2012, 98, 508–517. [Google Scholar] [CrossRef]
- Liu, H.; Wang, L.; Zhang, S.; Leng, J.; Li, N.; Li, W.; Wang, J.; Tian, H.; Qi, L.; Yang, X.; et al. One-year weight losses in the Tianjin Gestational Diabetes Mellitus Prevention Programme: A randomized clinical trial. Diabetes Obes. Metab. 2018, 20, 1246–1255. [Google Scholar] [CrossRef] [Green Version]
- Li, W.; Zhang, S.; Liu, H.; Wang, L.; Zhang, C.; Leng, J.; Yu, Z.; Yang, X.; Tian, H.; Hu, G. Different associations of diabetes with beta-cell dysfunction and insulin resistance among obese and nonobese Chinese women with prior gestational diabetes mellitus. Diabetes Care 2014, 37, 2533–2539. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liu, H.; Zhang, C.; Zhang, S.; Wang, L.; Leng, J.; Liu, D.; Fang, H.; Li, W.; Yu, Z.; Yang, X.; et al. Joint effects of pre-pregnancy body mass index and weight change on postpartum diabetes risk among gestational diabetes women. Obesity (Silver Spring) 2014, 22, 1560–1567. [Google Scholar] [CrossRef]
- WHO. WHO Consultation: Definition, Diagnosis and Classification of Diabetes mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes mellitus; World Health Organisation: Geneva, Switzerland, 1999. [Google Scholar]
- American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005, 28 (Suppl. 1), S37–S42. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hu, G. More vigorous efforts are needed to fight obesity, a serious public health problem in China. Obesity (Silver Spring) 2021, 29, 1580–1581. [Google Scholar] [CrossRef]
- Li, Y.P.; He, Y.N.; Zhai, F.Y.; Yang, X.G.; Hu, X.Q.; Zhao, W.; Ma, G. Comparison of assessment of food intakes by using 3 dietary survey methods. Chin. J. Prev. Med. 2006, 40, 273–279. [Google Scholar]
- Ma, G.; Luan, D.; Li, Y.; Liu, A.; Hu, X.; Cui, Z.; Zhai, F.; Yang, X. Physical activity level and its association with metabolic syndrome among an employed population in China. Obes. Rev. 2008, 9 (Suppl. 1), 113–118. [Google Scholar] [CrossRef]
- Ma, G.; Luan, D.; Liu, A.; Li, Y.; Cui, Z.; Hu, X.; Yang, X. The analysis and evaluation of a physical activity questionnaire of Chinese employed population. Nutr. Trans. 2007, 29, 217–221. [Google Scholar]
- Zhao, W.; Katzmarzyk, P.T.; Horswell, R.; Wang, Y.; Li, W.; Johnson, J.; Heymsfield, S.B.; Cefalu, W.T.; Ryan, D.H.; Hu, G. Body Mass Index and the Risk of All-Cause Mortality Among Patients with Type 2 Diabetes. Circulation 2014, 130, 2143–2151. [Google Scholar] [CrossRef]
- Shen, Y.; Shi, L.; Nauman, E.; Katzmarzyk, P.T.; Price-Haywood, E.G.; Bazzano, A.N.; Nigam, S.; Hu, G. Association between Body Mass Index and Stroke Risk Among Patients with Type 2 Diabetes. J. Clin. Endocrinol. Metab. 2020, 105, 96–105. [Google Scholar] [CrossRef] [Green Version]
- Wang, L.; Liu, H.; Zhang, S.; Leng, J.; Liu, G.; Zhang, C.; Li, W.Q.; Li, N.; Li, W.; Li, Y.; et al. Obesity index and the risk of diabetes among Chinese women with prior gestational diabetes. Diabet. Med. 2014, 31, 1368–1377. [Google Scholar] [CrossRef]
- American Diabetes Association. 8. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022, 45, S113–S124. [Google Scholar] [CrossRef] [PubMed]
- Wing, R.R.; Neiberg, R.H.; Bahnson, J.L.; Clark, J.M.; Espeland, M.A.; Hill, J.O.; Johnson, K.C.; Knowler, W.C.; Olson, K.; Steinburg, H.; et al. Weight Change During the Postintervention Follow-up of Look AHEAD. Diabetes Care 2022, 45, 1306–1314. [Google Scholar] [CrossRef] [PubMed]
- Wing, R.R.; Bray, G.A.; Cassidy-Begay, M.; Clark, J.M.; Coday, M.; Egan, C.; Evans, M.; Foreyt, J.P.; Glasser, S.; Gregg, E.W.; et al. Effects of Intensive Lifestyle Intervention on All-Cause Mortality in Older Adults with Type 2 Diabetes and Overweight/Obesity: Results From the Look AHEAD Study. Diabetes Care 2022, 45, 1252–1259. [Google Scholar]
- Franz, M.J.; Boucher, J.L.; Rutten-Ramos, S.; VanWormer, J.J. Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: A systematic review and meta-analysis of randomized clinical trials. J. Acad. Nutr. Diet. 2015, 115, 1447–1463. [Google Scholar] [CrossRef]
- Yeung, R.O.; Zhang, Y.Y.; Luk, A.; Yang, W.Y.; Sobrepena, L.; Yoon, K.H.; Aravind, S.R.; Sheu, W.Y.; Nguyen, T.K.; Ozaki, R.; et al. Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): A cross-sectional study of a prospective cohort. Lancet Diabetes Endocrinol. 2014, 2, 935–943. [Google Scholar] [CrossRef]
- Sattar, N.; Rawshani, A.; Franzen, S.; Rawshani, A.; Svensson, A.M.; Rosengren, A.; McGuire, D.K.; Eliasson, B.; Gudbjornsdottir, S. Age at Diagnosis of Type 2 Diabetes Mellitus and Associations with Cardiovascular and Mortality Risks Findings from the Swedish National Diabetes Registry. Circulation 2019, 139, 2228–2237. [Google Scholar] [CrossRef]
- Zhao, W.; Katzmarzyk, P.T.; Horswell, R.; Wang, Y.; Johnson, J.; Hu, G. HbA1c and Coronary Heart Disease Risk Among Diabetic Patients. Diabetes Care 2014, 37, 428–435. [Google Scholar] [CrossRef] [Green Version]
- Zhang, Y.; Hu, G.; Yuan, Z.; Chen, L. Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: A systematic review and meta-analysis. PLoS ONE 2012, 7, e42551. [Google Scholar] [CrossRef]
- Sacks, F.M.; Bray, G.A.; Carey, V.J.; Smith, S.R.; Ryan, D.H.; Anton, S.D.; McManus, K.; Champagne, C.M.; Bishop, L.M.; Laranjo, N.; et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N. Engl. J. Med. 2009, 360, 859–873. [Google Scholar] [CrossRef]
- Ferrara, A.; Hedderson, M.M.; Brown, S.D.; Albright, C.L.; Ehrlich, S.F.; Tsai, A.L.; Caan, B.J.; Sternfeld, B.; Gordon, N.P.; Schmittdiel, J.A.; et al. The Comparative Effectiveness of Diabetes Prevention Strategies to Reduce Postpartum Weight Retention in Women with Gestational Diabetes Mellitus: The Gestational Diabetes’ Effects on Moms (GEM) Cluster Randomized Controlled Trial. Diabetes Care 2016, 39, 65–74. [Google Scholar] [CrossRef]
Figure 1.
Participant flow chart.
Table 1.
Baseline characteristics among women with gestational diabetes mellitus (GDM) and newly diagnosed diabetes who attended and absented Month 9 and Years 6–9 follow-up visits.
Table 1.
Baseline characteristics among women with gestational diabetes mellitus (GDM) and newly diagnosed diabetes who attended and absented Month 9 and Years 6–9 follow-up visits.
| Total Samples | Month 9 visit | p-values | Year 6–9 Follow-Up Visit | p-Values | |||
|---|---|---|---|---|---|---|---|
| Attend | Absence | Attend | Absence | ||||
| No. of participants | 83 | 68 | 15 | 39 | 44 | ||
| Age at baseline (years) | 32.7 ± 3.84 | 33.2 ± 3.90 | 30.3 ± 2.47 | 0.007 | 33.7 ± 3.83 | 31.7 ± 3.64 | 0.016 |
| Baseline years after delivery (years) | 2.63 ± 0.95 | 2.73 ± 0.94 | 2.17 ± 0.88 | 0.034 | 2.69 ± 0.95 | 2.58 ± 0.96 | 0.628 |
| Characteristics of GDM | |||||||
| Fasting plasma glucose (mmol/L) | 6.01 ± 1.23 | 6.04 ± 1.31 | 5.88 ± 0.78 | 0.636 | 5.98 ± 1.41 | 6.04 ± 1.07 | 0.809 |
| 2-h plasma glucose (mmol/L) | 10.5 ± 1.75 | 10.6 ± 1.67 | 10.1 ± 2.06 | 0.249 | 10.7 ± 1.84 | 10.3 ± 1.67 | 0.355 |
| Gestational week at OGTT (weeks) | 28.5 ± 2.16 | 28.5 ± 2.21 | 28.5 ± 1.83 | 0.971 | 28.3 ± 2.56 | 28.7 ± 1.74 | 0.490 |
| Gestational age at delivery (weeks) | 38.5 ± 1.80 | 38.4 ± 1.88 | 38.9 ± 1.36 | 0.412 | 38.7 ± 1.71 | 38.3 ± 1.88 | 0.286 |
| Pre-pregnancy body mass index (kg/m2) | 25.6 ± 3.71 | 25.4 ± 3.77 | 26.5 ± 3.36 | 0.276 | 25.3 ± 3.05 | 25.8 ± 4.23 | 0.520 |
| Baseline survey | |||||||
| Body mass index (kg/m2) | 27.3 ± 4.04 | 27.1 ± 4.23 | 28.3 ± 2.89 | 0.272 | 27.1 ± 3.74 | 27.4 ± 4.32 | 0.738 |
| Waist circumference (cm) | 88.7 ± 9.62 | 88.0 ± 10.2 | 91.7 ± 5.97 | 0.170 | 88.3 ± 8.90 | 88.9 ± 10.3 | 0.775 |
| Body fat (%) | 37.8 ± 5.19 | 37.5 ± 5.46 | 39.5 ± 3.39 | 0.215 | 37.7 ± 4.84 | 38.0 ± 5.53 | 0.812 |
| Systolic blood pressure (mmHg) | 115 ± 15.1 | 115 ± 16.1 | 112 ± 9.57 | 0.405 | 115 ± 12.6 | 114 ± 17.2 | 0.670 |
| Diastolic blood pressure (mmHg) | 80.7 ± 11.2 | 81.2 ± 11.8 | 78.3 ± 7.96 | 0.360 | 81.6 ± 9.96 | 79.9 ± 12.3 | 0.484 |
| Fasting plasma glucose (mmol/L) | 7.64 ± 2.17 | 7.73 ± 2.27 | 7.23 ± 1.61 | 0.425 | 7.58 ± 1.85 | 7.69 ± 2.43 | 0.825 |
| 2-h plasma glucose (mmol/L) | 14.1 ± 3.01 | 14.3 ± 3.15 | 13.3 ± 2.14 | 0.250 | 14.3 ± 2.99 | 14.0 ± 3.06 | 0.702 |
| Fasting serum insulin (pmol/L) | 82.6 ± 68.0 | 82.9 ± 72.9 | 82.4 ± 45.4 | 0.985 | 88.2 ± 87.5 | 77.9 ± 46.0 | 0.492 |
| HbA1c (%) | 6.91 ± 1.23 | 6.94 ± 1.29 | 6.75 ± 0.92 | 0.577 | 6.83 ± 1.16 | 6.98 ± 1.30 | 0.591 |
| Plasma total cholesterol (mmol/L) | 4.92 ± 0.88 | 4.91 ± 0.91 | 4.95 ± 0.75 | 0.862 | 4.74 ± 0.90 | 5.07 ± 0.84 | 0.078 |
| High-density lipoprotein cholesterol (mmol/L) | 1.26 ± 0.27 | 1.28 ± 0.25 | 1.18 ± 0.32 | 0.171 | 1.28 ± 0.25 | 1.25 ± 0.28 | 0.259 |
| Low-density lipoprotein cholesterol (mmol/L) | 2.78 ± 1.02 | 2.85 ± 0.79 | 2.47 ± 1.72 | 0.189 | 2.73 ± 0.73 | 2.83 ± 1.23 | 0.692 |
| Plasma triglycerides (mmol/L) | 1.90 ± 2.31 | 1.69 ± 0.78 | 2.86 ± 5.20 | 0.077 | 1.60 ± 0.78 | 2.17 ± 3.08 | 0.656 |
| Use of glucose-lowering agents (%) | 2.4 | 2.9 | 0 | 0.527 | 2.6 | 2.3 | 0.595 |
| Leisure time physical activity (min/day) | 2.81 ± 7.96 | 3.31 ± 8.68 | 0.59 ± 2.04 | 0.234 | 2.63 ± 8.40 | 2.99 ± 7.64 | 0.839 |
| Dietary intake a | |||||||
| Energy intake (kcal/day) | 1708 ± 418 | 1720 ± 420 | 1653 ± 420 | 0.574 | 1738 ± 402 | 1681 ± 436 | 0.536 |
| Protein (% energy) | 16.0 ± 2.36 | 16.2 ± 2.37 | 15.3 ± 2.23 | 0.191 | 16.0 ± 2.36 | 16.0 ± 2.29 | 0.956 |
| Fat (% energy) | 33.3 ± 6.44 | 33.9 ± 6.21 | 30.5 ± 6.95 | 0.063 | 33.8 ± 6.85 | 32.9 ± 6.10 | 0.523 |
| Carbohydrate (% energy) | 50.7 ± 7.12 | 49.9 ± 6.75 | 54.2 ± 7.91 | 0.034 | 50.2 ± 7.82 | 51.1 ± 6.49 | 0.576 |
Data are presented as mean ± SD unless otherwise indicated. A one-way ANOVA and chi-square test were used to analyze the differences in continuous baseline measures and in categorical measures. a Dietary intake assessed was by 3-day 24 h food records.
Table 2.
Changes in body weight, energy intake, leisure time, and physical activity from baseline to the end of Months 1, 3, 6 and 9.
Table 2.
Changes in body weight, energy intake, leisure time, and physical activity from baseline to the end of Months 1, 3, 6 and 9.
| Month 1 | Month 3 | Month 6 | Month 9 | |
|---|---|---|---|---|
| No. of participants | 83 | 83 | 83 | 83 |
| Change in weight | ||||
| (kg) | −1.82 ± 2.51 | −2.81 ± 3.19 | −3.21 ± 3.73 | −2.90 ± 3.77 |
| Percent reduction in initial weight | −2.54 ± 3.62 | −3.97 ± 4.61 | −4.52 ± 5.37 | −4.02 ± 5.34 |
| Change in energy intakes (kcal/day) a | −242 ± 451 | −240 ± 414 | −227 ± 416 | −61.7 ± 371 |
| Change in leisure time physical activity (min/day) | 4.27 ± 16.8 | 4.97 ± 12.5 | 7.61 ± 20.4 | 8.46 ± 24.3 |
Data are presented as changes in mean ± SD unless otherwise indicated. A monotone missing pattern was observed among the missing values, and multiple imputations using a regression model were performed. a Dietary intake was assessed by 3-day 24 h food records.
Table 3.
Changes in selected clinical and metabolic variables from baseline to the end of Month 9 and Years 6–9 visits.
Table 3.
Changes in selected clinical and metabolic variables from baseline to the end of Month 9 and Years 6–9 visits.
| Baseline | Month 9 | Changes from Baseline to Month 9 | p-Values | Years 6–9 | Changes from Baseline to Years 6–9 | p-Values | |
|---|---|---|---|---|---|---|---|
| No. of participants | 83 | 83 | 83 | 83 | 83 | ||
| Age at baseline or during follow-up (years) | 32.7 ± 3.84 | 33.8 ± 3.94 | 39.5 ± 3.98 | ||||
| Follow-up from baseline (years) | 1.12 ± 0.34 | 6.79 ± 1.13 | |||||
| Body weight (kg) | 70.2 ± 11.1 | 67.3 ± 11.0 | −2.90 ± 3.77 | < 0.001 | 66.5 ± 9.03 | −3.71 ± 6.02 | < 0.001 |
| Percent change in initial weight | −4.02 ± 5.34 | −4.62 ± 8.30 | |||||
| Body mass index (kg/m2) | 27.3 ± 4.04 | 26.2 ± 4.04 | −1.12 ± 1.48 | < 0.001 | 25.7 ± 3.13 | −1.57 ± 2.35 | < 0.001 |
| Waist circumference (cm) | 88.7 ± 9.62 | 85.6 ± 9.84 | −3.12 ± 5.94 | < 0.001 | 84.1 ± 8.48 | −4.56 ± 7.41 | < 0.001 |
| Body fat (%) | 37.9 ± 5.19 | 36.1 ± 5.57 | −1.75 ± 2.28 | < 0.001 | 35.8 ± 4.51 | −2.10 ± 3.20 | < 0.001 |
| Systolic blood pressure (mmHg) | 115 ± 15.1 | 116 ± 14.8 | 1.63 ± 12.7 | 0.305 | 119 ± 16.4 | 3.88 ± 14.4 | 0.072 |
| Diastolic blood pressure (mmHg) | 80.7 ± 11.2 | 77.2 ± 11.0 | −3.49 ± 9.93 | 0.009 | 79.0 ± 10.7 | −1.64 ± 8.22 | 0.155 |
| Fasting plasma glucose (mmol/L) | 7.64 ± 2.17 | 6.66 ± 1.99 | −0.98 ± 1.80 | < 0.001 | 8.28 ± 2.72 | 0.64 ± 2.81 | 0.099 |
| Fasting serum insulin (pmol/L) | 82.6 ± 68.0 | 67.0 ± 48.8 | −15.5 ± 58.3 | 0.031 | 71.8 ± 41.0 | −10.8 ± 49.3 | 0.073 |
| HbA1c (%) | 6.91 ± 1.23 | 6.19 ± 1.21 | −0.72 ± 1.02 | < 0.001 | 7.13 ± 1.54 | 0.22 ± 1.76 | 0.345 |
| Total cholesterol (mmol/L) | 4.92 ± 0.88 | 4.86 ± 0.94 | −0.06 ± 0.69 | 0.507 | 5.12 ± 1.32 | 0.20 ± 1.12 | 0.241 |
| High-density lipoprotein cholesterol (mmol/L) | 1.26 ± 0.27 | 1.24 ± 0.30 | −0.02 ± 0.24 | 0.470 | 1.31 ± 0.29 | 0.05 ± 0.25 | 0.135 |
| Low-density lipoprotein cholesterol (mmol/L) | 2.78 ± 1.02 | 2.78 ± 1.04 | 0.00 ± 0.78 | 0.968 | 2.97 ± 0.85 | 0.19 ± 0.97 | 0.136 |
| Triglycerides (mmol/L) | 1.90 ± 2.29 | 1.74 ± 2.54 | −0.16 ± 1.85 | 0.508 | 1.56 ± 1.74 | −0.34 ± 2.41 | 0.221 |
| Use of glucose-lowering agents (%) | 2.41 | 34.6 | 32.2 | 48.4 | 46.0 |
Data are presented as mean ± SD unless otherwise indicated. A monotone missing pattern was observed among the missing values, and multiple imputations using a regression model were performed. A two-tailed paired t test was used to analyze the differences in continuous measures between the two groups.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Hu, G.; Liu, H.; Leng, J.; Wang, L.; Li, W.; Zhang, S.; Li, W.; Liu, G.; Tian, H.; Yang, S.; et al. Effects of a Lifestyle Intervention in Young Women with GDM and Subsequent Diabetes. Nutrients 2022, 14, 5232. https://doi.org/10.3390/nu14245232
AMA Style
Hu G, Liu H, Leng J, Wang L, Li W, Zhang S, Li W, Liu G, Tian H, Yang S, et al. Effects of a Lifestyle Intervention in Young Women with GDM and Subsequent Diabetes. Nutrients. 2022; 14(24):5232. https://doi.org/10.3390/nu14245232
Chicago/Turabian StyleHu, Gang, Huikun Liu, Junhong Leng, Leishen Wang, Weiqin Li, Shuang Zhang, Wei Li, Gongshu Liu, Huiguang Tian, Shengping Yang, and et al. 2022. "Effects of a Lifestyle Intervention in Young Women with GDM and Subsequent Diabetes" Nutrients 14, no. 24: 5232. https://doi.org/10.3390/nu14245232
APA StyleHu, G., Liu, H., Leng, J., Wang, L., Li, W., Zhang, S., Li, W., Liu, G., Tian, H., Yang, S., Yu, Z., Yang, X., & Tuomilehto, J. (2022). Effects of a Lifestyle Intervention in Young Women with GDM and Subsequent Diabetes. Nutrients, 14(24), 5232. https://doi.org/10.3390/nu14245232
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
